Medi Assist H1 FY27 Income Rises 13.8% to INR 492.4 Crore
Key highlights
- Medi Assist reported H1 FY27 consolidated income of INR 492.4 crore, up 13.8% year on year.
- H1 FY27 EBITDA rose 19% to INR 97.2 crore and the EBITDA margin increased to 20.3%.
- Q2 FY27 operating revenue was INR 241.5 crore, up 3.9%, while EBITDA margin reached 24.4%.
- India TPA revenue was INR 437.5 crore in H1 FY27 and premiums managed reached INR 15,104 crore.
powered by IRIS

Medi Assist Healthcare Services Limited reported consolidated income of INR 492.4 crore for H1 FY27, a 13.8% year-on-year increase, while EBITDA rose 19% to INR 97.2 crore. The result matters because the company reported stronger profitability alongside the completed integration of Paramount and continued growth in its India third-party administrator business.
Know Medi Assist Healthcare Services inside out
Results, valuation, peers and who's buying, in one view.
What did Medi Assist report for H1 FY27?
Medi Assist reported consolidated income of INR 492.4 crore in the first half of FY27, compared with the year-earlier period, representing growth of 13.8%. Operating revenue, defined by the company as revenue from contracts with customers excluding other income, rose 13.0% year on year to INR 478 crore.
Profitability grew faster than income during the half year. EBITDA increased 19% to INR 97.2 crore, and the EBITDA margin expanded by 103 basis points to 20.3%. Reported profit after tax rose 60% year on year to INR 49.2 crore, according to management's earnings-call remarks.
The results were discussed by Chief Executive Officer Satish Gidugu and Chief Financial Officer Sandeep Daga during the Q2 and H1 FY27 earnings call held on November 2, 2026. Management described the first half as a period in which the India business remained a cash-generating base while the technology platform and international operations contributed to growth and margin expansion.
How did Medi Assist perform in the September quarter?
Medi Assist recorded total income of INR 245.4 crore in Q2 FY27, up 4.5% year on year, while operating revenue rose 3.9% to INR 241.5 crore. The quarterly growth rate was lower than the first-half increase, but the company reported a marked improvement in operating margin.
Q2 EBITDA margin reached 24.4%, an expansion of 331 basis points from a year earlier. Separately reported Q2 results showed consolidated revenue of INR 241.51 crore, compared with INR 232.55 crore a year earlier, and net profit of INR 21.58 crore, versus INR 8.07 crore in the corresponding quarter.
Management said the September quarter was the first like-for-like quarter following the Paramount acquisition. It said the integration had been completed and Paramount operations were running on the MAtrix platform. This integration is relevant because the acquired business now forms part of the comparable operating base used for future quarterly assessments.
Which businesses supported Medi Assist's first-half growth?
Medi Assist's India TPA business remained its largest operating segment, generating H1 revenue of INR 437.5 crore, up 11.9% year on year. The segment accounted for about 91.5% of consolidated revenue, underlining the continuing importance of the domestic third-party administrator franchise.
Premiums managed by the India TPA business rose 18.8% year on year to INR 15,104 crore. These managed premiums are not company revenue, but they indicate the scale of insurance-related administration handled by the business. The platform and health benefit administrator business generated INR 19.8 crore of revenue, with growth of nearly 70% year on year.
The company also cited Mayfair's international expansion as part of its growth strategy. Management presented the India TPA franchise as a stable operating platform, with the technology and international businesses positioned as additional contributors to revenue growth and margin improvement. No separate financial contribution for the international business was disclosed in the supplied earnings-call details.
Got a follow-up? Ask IRIS
What are the key financial figures from the earnings call?
The key figures show that Medi Assist delivered double-digit H1 income and operating-revenue growth, while EBITDA increased at a faster pace. The gap between revenue and EBITDA growth resulted in the 103-basis-point expansion in first-half EBITDA margin.
Medi Assist also said it had a debt-free balance sheet and had approved a buyback of INR 49.3 crore. The buyback indicates a planned shareholder return, while the stated absence of debt gives the company financial flexibility. The supplied material did not provide the buyback price, record date, or completion timetable.
How do the results affect investors and industry participants?
For investors, the earnings call provides evidence that Medi Assist's operating profitability improved despite Q2 operating-revenue growth moderating to 3.9%. The stronger Q2 margin and 19% H1 EBITDA growth are the central financial indicators from the update, while the India TPA business continued to supply most of the company's revenue.
For insurers, employers, hospitals and covered members that use third-party administration services, the relevant operating indicator is the INR 15,104 crore of premiums managed by the India TPA business. The completed Paramount integration and migration to the MAtrix platform are operational developments that management linked to its ability to run the combined business.
Management said it expects retention rates to return to historical levels of 93% to 94% over the next three to four quarters. It also indicated that this could support same-store growth of about 9%. These are management expectations, not reported results, and their progress will be measurable in subsequent disclosures through retention, revenue and margin data.
Conclusion
Medi Assist's H1 FY27 update showed income growth of 13.8% to INR 492.4 crore, EBITDA growth of 19% to INR 97.2 crore and a higher operating margin. The India TPA unit remained the principal source of revenue, while the platform business expanded rapidly from a smaller base and the Paramount integration reached completion.
The next disclosures will be relevant for evidence of the retention recovery management expects within three to four quarters, as well as the planned INR 49.3 crore buyback. Investors will also be able to assess whether the Q2 EBITDA margin of 24.4% and the stated growth in managed premiums are sustained in later reporting periods.


